20 results
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws
6-K
EX-1.1
09nc muvq
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-10.1
2gsx8az 6602
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-1.1
1at iaehsi
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
mdzi6iqurw
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-99.2
31ry9wb2 syx0iilgi
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
fn8cwq uvx0xjo60w95
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
EX-99.1
zhzxs555yym elxni
24 Oct 16
Bioblast Announces Results of Trehalose Clinical Study
12:00am
6-K
EX-99.2
42hftye
27 Oct 15
Current report (foreign)
12:00am
6-K
EX-99.1
8qfg1atjtr4 6eqly
27 Oct 15
Current report (foreign)
12:00am
- Prev
- 1
- Next